National Healthcare (NHC) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $245.53, +4.71% vs the prior close of $234.48.
- Volume 95.90K shares, 0.9x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
NHC jumps 4.7% to $245.53, a 52-week high, 6 up days in a row. Closed at $245.53, +4.71% vs the prior close of $234.48. Day range $236.68–$245.64, opened at $236.68.
NHC daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — NHC jumps 4.7% to $245.53, a 52-week high, 6 up days in a row
- Closed at $245.53, +4.71% vs the prior close of $234.48. Day range $236.68–$245.64, opened at $236.68.
- Volume was 95.90K shares, 0.9x its 50-day average of 105.16K.
- Price is +9.0% vs its 50-day average ($225.18) and +30.0% vs its 200-day average ($188.87).
- 52-week range $118.14–$245.64; today's close sits at 100% of that range, 0.0% below the 52-week high.
- That makes 6 straight gains.
Oct 14, 2026 — NHC rises 1.3% to $234.48, a 1-month high, 5 up days in a row
- Closed at $234.48, +1.34% vs the prior close of $231.39. Day range $230.55–$234.65, opened at $230.55.
- Volume was 80.80K shares, 0.8x its 50-day average of 106.88K.
- Price is +4.4% vs its 50-day average ($224.70) and +24.5% vs its 200-day average ($188.34).
- 52-week range $117.22–$239.29; today's close sits at 96% of that range, 2.0% below the 52-week high.
- That makes 5 straight gains.
Oct 13, 2026 — NHC rises 0.7% to $231.39, a 1-month high, 4 up days in a row
- Closed at $231.39, +0.66% vs the prior close of $229.88. Day range $229.40–$232.77, opened at $231.01.
- Volume was 51.50K shares, 0.5x its 50-day average of 107.97K — lighter than usual.
- Price is +3.2% vs its 50-day average ($224.17) and +23.2% vs its 200-day average ($187.86).
- 52-week range $117.22–$239.29; today's close sits at 94% of that range, 3.3% below the 52-week high.
- That makes 4 straight gains.
Oct 12, 2026 — NHC rises 1.2% to $229.88, 3 up days in a row
- Closed at $229.88, +1.22% vs the prior close of $227.11. Day range $226.90–$230.96, opened at $226.90.
- Volume was 65.30K shares, 0.6x its 50-day average of 108.38K.
- Price is +2.6% vs its 50-day average ($224.00) and +22.7% vs its 200-day average ($187.39).
- 52-week range $116.42–$239.29; today's close sits at 92% of that range, 3.9% below the 52-week high.
- That makes 3 straight gains.
Oct 9, 2026 — NHC rises 0.9% to $227.11
- Closed at $227.11, +0.86% vs the prior close of $225.17. Day range $223.76–$227.95, opened at $224.74.
- Volume was 62.80K shares, 0.6x its 50-day average of 110.08K — lighter than usual.
- Price is +1.4% vs its 50-day average ($223.92) and +21.5% vs its 200-day average ($186.94).
- 52-week range $116.42–$239.29; today's close sits at 90% of that range, 5.1% below the 52-week high.
Oct 8, 2026 — NHC rises 1.8% to $225.17
- Closed at $225.17, +1.80% vs the prior close of $221.19. Day range $220.52–$226.76, opened at $221.08.
- Volume was 82.20K shares, 0.7x its 50-day average of 110.07K.
- Price is +0.5% vs its 50-day average ($223.96) and +20.7% vs its 200-day average ($186.51).
- 52-week range $116.42–$239.29; today's close sits at 89% of that range, 5.9% below the 52-week high.
Oct 7, 2026 — NHC slides 3.1% to $221.19
- Closed at $221.19, -3.10% vs the prior close of $228.27. Day range $220.40–$229.19, opened at $225.99.
- Volume was 100.90K shares, 0.9x its 50-day average of 109.36K.
- Price is -1.3% vs its 50-day average ($224.03) and +18.9% vs its 200-day average ($186.10).
- 52-week range $116.42–$239.29; today's close sits at 85% of that range, 7.6% below the 52-week high.
Oct 6, 2026 — NHC dips 0.9% to $228.27
- Closed at $228.27, -0.91% vs the prior close of $230.37. Day range $227.26–$231.94, opened at $231.31.
- Volume was 90.60K shares, 0.8x its 50-day average of 109.60K.
- Price is +1.8% vs its 50-day average ($224.23) and +22.9% vs its 200-day average ($185.70).
- 52-week range $116.42–$239.29; today's close sits at 91% of that range, 4.6% below the 52-week high.
Oct 5, 2026 — NHC rises 1.2% to $230.37, a 1-month high, 3 up days in a row
- Closed at $230.37, +1.19% vs the prior close of $227.66. Day range $223.40–$232.17, opened at $227.11.
- Volume was 112.70K shares, 1.0x its 50-day average of 108.79K.
- Price is +2.8% vs its 50-day average ($224.18) and +24.3% vs its 200-day average ($185.26).
- 52-week range $116.42–$239.29; today's close sits at 93% of that range, 3.7% below the 52-week high.
- That makes 3 straight gains.
Oct 2, 2026 — NHC rises 1.9% to $227.66
- Closed at $227.66, +1.93% vs the prior close of $223.35. Day range $223.80–$229.53, opened at $225.08.
- Volume was 88.30K shares, 0.8x its 50-day average of 109.49K.
- Price is +1.6% vs its 50-day average ($224.09) and +23.2% vs its 200-day average ($184.80).
- 52-week range $116.42–$239.29; today's close sits at 91% of that range, 4.9% below the 52-week high.
NHC latest news & SEC filings
Every SEC filing by or about NHC in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 23, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Dodson Vicki L sold 4,834 shares at $225.00 (≈$1.09M) on Sep 22, 2026; now holds 10,726
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 14, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Mccreary Josh A sold 1,291 shares at $225.09 (≈$290.59K) on Sep 10, 2026
- Mccreary Josh A sold 789 shares at $223.78 (≈$176.56K) on Sep 10, 2026
- Mccreary Josh A sold 571 shares at $222.73 (≈$127.18K) on Sep 10, 2026
- Mccreary Josh A sold 68 shares at $225.59 (≈$15.34K) on Sep 10, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 14, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Kidd Brian F sold 6,813 shares at $225.70 (≈$1.54M) on Sep 11, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 10, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 2, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Flatt Ben Anderson Sr sold 1,000 shares at $222.50 (≈$222.50K) on Aug 28, 2026
- Flatt Ben Anderson Sr sold 1,000 shares at $227.00 (≈$227.00K) on Aug 25, 2026
- Flatt Ben Anderson Sr sold 1,000 shares at $237.00 (≈$237.00K) on Aug 20, 2026
- Flatt Ben Anderson Sr sold 1,000 shares at $237.18 (≈$237.18K) on Aug 19, 2026
- Flatt Ben Anderson Sr sold 1,000 shares at $226.00 (≈$226.00K) on Aug 17, 2026
- Flatt Ben Anderson Sr sold 1,000 shares at $222.11 (≈$222.11K) on Aug 14, 2026
- …plus 1 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 28, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Gifford David R. sold 1,779 shares at $225.42 (≈$401.02K) on Aug 25, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 11, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 11, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 6, 2026 · 10-Q — Quarterly report (unaudited financial statements for the quarter)
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $408.02M (prior year $374.91M) (+8.8% vs Jun 30, 2025)
- Net income: $40.32M (prior year $23.72M) (+70.0% vs Jun 30, 2025)
- Diluted EPS: $2.54 (prior year $1.52) (+67.1% vs Jun 30, 2025)
Jul 27, 2026 · SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 1, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 1.02 — Ended a material agreement.
- Item 2.01 — Completed an acquisition or sale of assets.
- Item 2.03 — Took on a new material debt or financial obligation.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Things to know before you trade NHC
- Last results release: Aug 11, 2026 (8-K Item 2.02). Previous ones: May 8, 2026, Feb 27, 2026, Nov 7, 2025. Based on that rhythm, the next report is likely around Nov 10, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.49% (largest 4.7%).
- Liquidity: about 111.96K shares (≈$27.49M) trade per day on average.
- 52-week position: $245.53 vs a range of $118.14–$245.64 (100% of the range).
- Dividends: last ex-dividend date Sep 30, 2026 ($0.67/share); 4 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 1 open-market buys, 23 sales; latest: Vicki L Dodson sold 4,834 shares on Sep 22, 2026.
- Latest filings: 8-K Aug 11, 2026; 8-K Aug 11, 2026; 10-Q Aug 6, 2026.
- Share count: 15.66M shares outstanding (Aug 3, 2026), +1.0% vs a year earlier.
- Listing: NYSE · industry: Services-Skilled Nursing Care Facilities.
NHC market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 236.68 | 245.64 | 236.68 | 245.53 | 95.90K |
| Oct 14, 2026 | 230.55 | 234.65 | 230.55 | 234.48 | 80.80K |
| Oct 13, 2026 | 231.01 | 232.77 | 229.40 | 231.39 | 51.50K |
| Oct 12, 2026 | 226.90 | 230.96 | 226.90 | 229.88 | 65.30K |
| Oct 9, 2026 | 224.74 | 227.95 | 223.76 | 227.11 | 62.80K |
| Oct 8, 2026 | 221.08 | 226.76 | 220.52 | 225.17 | 82.20K |
| Oct 7, 2026 | 225.99 | 229.19 | 220.40 | 221.19 | 100.90K |
| Oct 6, 2026 | 231.31 | 231.94 | 227.26 | 228.27 | 90.60K |
| Oct 5, 2026 | 227.11 | 232.17 | 223.40 | 230.37 | 112.70K |
| Oct 2, 2026 | 225.08 | 229.53 | 223.80 | 227.66 | 88.30K |
| Oct 1, 2026 | 220.27 | 224.91 | 220.14 | 223.35 | 99.90K |
| Sep 30, 2026 | 224.21 | 224.30 | 219.51 | 219.51 | 116.80K |
| Sep 29, 2026 | 225.90 | 227.58 | 220.55 | 224.16 | 105.20K |
| Sep 28, 2026 | 226.20 | 228.96 | 223.12 | 225.97 | 92.60K |
| Sep 25, 2026 | 221.42 | 229.45 | 221.42 | 227.36 | 156.20K |
| Sep 24, 2026 | 224.20 | 225.16 | 219.72 | 221.60 | 84.40K |
| Sep 23, 2026 | 222.62 | 227.10 | 220.45 | 224.87 | 109.80K |
| Sep 22, 2026 | 224.01 | 225.72 | 220.71 | 222.86 | 71.90K |
| Sep 21, 2026 | 223.34 | 225.29 | 221.80 | 223.31 | 103.60K |
| Sep 18, 2026 | 224.21 | 229.05 | 220.54 | 222.11 | 467.80K |
About National Healthcare
National Healthcare (NHC) is listed on the NYSE and classified by the SEC under “Services-Skilled Nursing Care Facilities”. Its business address is in MURFREESBORO, TN. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1047335.
NHC board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| James Paul Abernathy | Director | May 7, 2026 |
| Robert G Adams | Director | Jun 10, 2026 |
| William A. Adams | Director | May 8, 2026 |
| Stephen Fowler Flatt | CEO | Aug 20, 2026 |
| David R. Gifford | Director | Aug 28, 2026 |
| Emil E Hassan | Director | Jun 23, 2026 |
| Richard F Jr Laroche | Director | May 22, 2026 |
| Lisa Piercey | Director | Jun 2, 2026 |
| Sandra Y. Trail | Director | May 8, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Vicki L Dodson | Sr.VP Patient Srvcs | Sep 23, 2026 |
| Ben Anderson Sr Flatt | Senior VP & CIO | Sep 2, 2026 |
| Stephen Fowler Flatt | CEO | Aug 20, 2026 |
| Brian F Kidd | SVP, CFO | Sep 14, 2026 |
| Josh A Mccreary | Senior VP & General Counsel | Sep 14, 2026 |
| Timothy J. Shelly | Sr.VP Operations | May 20, 2026 |
| Robert Michael Ussery | President & COO | Jan 5, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 22, 2026 | Vicki L Dodson | Sale | 4,834 | $225.00 |
| Sep 11, 2026 | Brian F Kidd | Sale | 6,813 | $225.70 |
| Sep 10, 2026 | Josh A Mccreary | Sale | 1,291 | $225.09 |
| Sep 10, 2026 | Josh A Mccreary | Sale | 789 | $223.78 |
| Sep 10, 2026 | Josh A Mccreary | Sale | 571 | $222.73 |
| Sep 10, 2026 | Josh A Mccreary | Sale | 68 | $225.59 |
| Aug 28, 2026 | Ben Anderson Sr Flatt | Sale | 1,000 | $222.50 |
| Aug 25, 2026 | David R. Gifford | Sale | 1,779 | $225.42 |
| Aug 25, 2026 | Ben Anderson Sr Flatt | Sale | 1,000 | $227.00 |
| Aug 20, 2026 | Ben Anderson Sr Flatt | Sale | 1,000 | $237.00 |
| Aug 19, 2026 | Stephen Fowler Flatt | Sale | 1,500 | $237.08 |
| Aug 19, 2026 | Ben Anderson Sr Flatt | Sale | 1,000 | $237.18 |
| Aug 17, 2026 | Ben Anderson Sr Flatt | Sale | 1,000 | $226.00 |
| Aug 14, 2026 | Ben Anderson Sr Flatt | Sale | 1,000 | $222.11 |
| Aug 12, 2026 | Ben Anderson Sr Flatt | Sale | 1,000 | $221.21 |
NHC financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $1.52B | $120.02M | 7.67 | $185.08M |
| Dec 31, 2024 | $1.31B | $101.93M | 6.53 | $107.30M |
| Dec 31, 2023 | $1.14B | $66.80M | 4.34 | $111.22M |
| Dec 31, 2022 | $1.09B | $22.45M | 1.45 | $8.74M |
| Dec 31, 2021 | $1.07B | $138.59M | 8.99 | $62.39M |
Latest balance sheet: total assets $1.54B, total liabilities $408.87M, cash $39.21M (as of Jun 30, 2026).
NHC earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 11, 2026 | 8-K Item 2.02 (results) | $216.69 |
| May 8, 2026 | 8-K Item 2.02 (results) | $188.82 |
| Feb 27, 2026 | 8-K Item 2.02 (results) | $163.50 |
| Nov 7, 2025 | 8-K Item 2.02 (results) | $127.17 |
| Aug 8, 2025 | 8-K Item 2.02 (results) | $100.38 |
| May 9, 2025 | 8-K Item 2.02 (results) | $100.54 |
| Feb 27, 2025 | 8-K Item 2.02 (results) | $93.33 |
| Nov 12, 2024 | 8-K Item 2.02 (results) | $130.62 |
| Aug 9, 2024 | 8-K Item 2.02 (results) | — |
| May 10, 2024 | 8-K Item 2.02 (results) | — |
| Feb 16, 2024 | 8-K Item 2.02 (results) | — |
| Nov 3, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Services-Skilled Nursing Care Facilities
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on NHC
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.